Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

August 01, 1988; Volume 34,Issue 2
  • You have access
    Characterization of the omega-conotoxin-binding molecule in rat brain synaptosomes and cultured neurons.
    B Marqueze, N Martin-Moutot, C Levêque and F Couraud
    Molecular Pharmacology August 1988, 34 (2) 87-90;
  • You have access
    Dopamine D2 receptor binding subunits of Mr congruent to 140,000 and 94,000 in brain: deglycosylation yields a common unit of Mr congruent to 44,000.
    K R Jarvie, H B Niznik and P Seeman
    Molecular Pharmacology August 1988, 34 (2) 91-97;
  • You have access
    Voltage-dependent block by strychnine of N-methyl-D-aspartic acid-activated cationic channels in rat cortical neurons in culture.
    M Bertolino and S Vicini
    Molecular Pharmacology August 1988, 34 (2) 98-103;
  • You have access
    Effect of the N-glycosidic bond conformation and modifications in the pentose moiety on the binding of nucleoside ligands to uridine phosphorylase.
    M H el Kouni, F N Naguib, S H Chu, S M Cha, T Ueda, G Gosselin, J L Imbach, Y F Shealy and B A Otter
    Molecular Pharmacology August 1988, 34 (2) 104-110;
  • You have access
    Effects of guanine nucleotides on N-methyl-D-aspartate receptor-ligand interactions.
    J B Monahan, W F Hood, J Michel and R P Compton
    Molecular Pharmacology August 1988, 34 (2) 111-116;
  • You have access
    Effects of thiol-reagents on [3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to rat telencephalic membranes.
    T Terramani, M Kessler, G Lynch and M Baudry
    Molecular Pharmacology August 1988, 34 (2) 117-123;
  • You have access
    In vivo binding of beta-carbolines in mice: regional differences and correlation of occupancy to pharmacological effects.
    M C Potier, L Prado de Carvalho, R H Dodd, R Besselievre and J Rossier
    Molecular Pharmacology August 1988, 34 (2) 124-128;
  • You have access
    Benzodiazepine interactions with GABAA receptors on chick ciliary ganglion neurons.
    A E McEachern and D K Berg
    Molecular Pharmacology August 1988, 34 (2) 129-135;
  • You have access
    Polyclonal and monoclonal antibodies directed against SK & F 94461, a specific H1 histamine receptor ligand.
    L Chatenoud, F Villemain, J Hoebeke, M Garbarg, M Korner, C Gros, M Ruat, P A Cazenave, C R Ganellin and J F Bach
    Molecular Pharmacology August 1988, 34 (2) 136-144;
  • You have access
    High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    L Tahraoui, A Floch, S Mondot and I Cavero
    Molecular Pharmacology August 1988, 34 (2) 145-151;
  • You have access
    Four polypeptide components of green mamba venom selectively block certain potassium channels in rat brain synaptosomes.
    C G Benishin, R G Sorensen, W E Brown, B K Krueger and M P Blaustein
    Molecular Pharmacology August 1988, 34 (2) 152-159;
  • You have access
    Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    U Kragh-Hansen
    Molecular Pharmacology August 1988, 34 (2) 160-171;
  • You have access
    Potential-dependent allosteric modulation of 1,4-dihydropyridine binding by d-(cis)-diltiazem and (+/-)-verapamil in living cardiac cells.
    H Porzig and C Becker
    Molecular Pharmacology August 1988, 34 (2) 172-179;
  • You have access
    The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells.
    W D Klohs and R W Steinkampf
    Molecular Pharmacology August 1988, 34 (2) 180-185;
  • You have access
    Prostaglandin hydroperoxidase-dependent oxidation of phenylbutazone: relationship to inhibition of prostaglandin cyclooxygenase.
    M F Hughes, R P Mason and T E Eling
    Molecular Pharmacology August 1988, 34 (2) 186-193;
  • You have access
    Physical characterization of a monoamine-sulfating form of phenol sulfotransferase from human platelets.
    J A Heroux and J A Roth
    Molecular Pharmacology August 1988, 34 (2) 194-199;
  • You have access
    Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study.
    C M Lin, S B Singh, P S Chu, R O Dempcy, J M Schmidt, G R Pettit and E Hamel
    Molecular Pharmacology August 1988, 34 (2) 200-208;
  • You have access
    Liver membrane calcium transport in diquat-induced oxidative stress in vivo.
    J O Tsokos-Kuhn, C V Smith, H Hughes and J R Mitchell
    Molecular Pharmacology August 1988, 34 (2) 209-214;
  • You have access
    The non-human primate: a possible model for human genetically determined polymorphisms in oxidative drug metabolism.
    E Jacqz, C Billante, F Moysan and H Mathieu
    Molecular Pharmacology August 1988, 34 (2) 215-217;
  • You have access
    Computer-automated structure evaluation of flavonoids and other structurally related compounds as glyoxalase I enzyme inhibitors.
    G Klopman and M L Dimayuga
    Molecular Pharmacology August 1988, 34 (2) 218-222;
  • You have access
    Metabolites and DNA adduct formation from flavoenzyme-activated porfiromycin.
    S S Pan and T Iracki
    Molecular Pharmacology August 1988, 34 (2) 223-228;
  • You have access
    Kinetic and equilibrium studies of Ah receptor-ligand binding: use of [125I]2-iodo-7,8-dibromodibenzo-p-dioxin.
    C A Bradfield, A S Kende and A Poland
    Molecular Pharmacology August 1988, 34 (2) 229-237;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 34, Issue 2
1 Aug 1988
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Proteomic Analysis of GPCR Cell Biology
  • Phosphoproteomic Analysis of cAMP-Dependent Pathways
  • Phosphoproteomic Identification of Signaling Pathways
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Characterization of GRD and LCCH3 from Human Louse
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics